[18F]FAraG (VisAcT) PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy
a study on Cancer, General
Summary
- Eligibility
- for people ages 18–65 (full criteria)
- Location
- at San Francisco, California
- Dates
- study startedestimated completion:
- Principal Investigator
- Henry VanBrocklin
Description
Summary
Official Title
Details
Keywords
Eligibility
Location
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- CellSight Technologies, Inc.
- ID
- NCT03142204
- Phase
- Phase 1
- Lead Scientist
- Henry VanBrocklin
- Study Type
- Interventional
- Last Updated
- July 18, 2017